Effect of Evidence-Based Skin Care and Hydrocolloid Dressing in the Prevention of Nasogastric-Related Pressure Injury

Summary

This study was planned as a prospective randomized controlled clinical trial to determine the effect of evidence-based skin care interventions and hydrocolloid dressings in preventing nasogastric induced pressure injuries in critically ill patients.

Conditions

• Medical Device Site Injury
• Nasogastric Tube
• Pressure Injury

Interventions

OTHER

skin care arm of where evidence-based practices in the implementation guide

1. The nasal mucosa and nasal skin under the nasogastric tube will be cleaned and dried twice a day with a pH-compatible cleanser. 2. A water-based moisturizing cream will be applied to the nasal skin under the nasogastric tube twice a day, after care with a pH-compatible cleanser. 3. Spray skin barrier will be applied twice a day after applying water-based moisturizing cream to the nasal skin under the nasogastric tube. 4. The nasal mucosa and nasal skin under the nasogastric tube will be evaluated twice daily for signs of pressure-related injury. All these care interventions applied to the skin care arm will be applied together with the doctor and nurse responsible for the treatment and care of the patient.

DEVICE

hydrocolloid (Convatec Granuflex-extra thin) dressing

The nasal skin of the patients and the surrounding skin will be cleaned with a pH-compatible cleaner, dried and a new hydrocolloid cover will be applied once a day. All these care interventions applied to the hydrocolloid dressing arm will be applied together with the physician and nurse responsible for the treatment and care of the patient.

OTHER

control

In routine care, the skin under the nasogastric tube is evaluated once a day for redness and wound formation by the nurse responsible for the patient's care and is cleaned and dried with appropriate cleaners.

Sponsors & Collaborators

• Necmettin Erbakan University

  collaborator OTHER

• MAİDE YEŞİLYURT

  lead OTHER

Principal Investigators

• SERPİL YÜKSEL, PhD · Necmettin Erbakan University

• ALPER YOSUNKAYA, PhD · Necmettin Erbakan University

• MAİDE YEŞİLYURT, MSc · Necmettin Erbakan University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-01-15

Primary Completion

2022-01-15

Completion

2022-06-15

Countries

• Turkey (Türkiye)

Study Locations